MAPK signaling pathway may be involved in the carcinogenesis and development of human meningiomas by binding to HER-2 [28], and inhibition of MAPK signaling pathway inhibition also suppresses glioma development [29]. The gene discussed is ERBB2; the disease is central nervous system cancer.